Skip to main content
Pathology and Oncology Research logoLink to Pathology and Oncology Research
. 2022 May 18;28:1610517. doi: 10.3389/pore.2022.1610517

Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination

Daniel Deme 1,*, Sandor Kovacs 2, Andras Telekes 1
PMCID: PMC9159149  PMID: 35665408

In the original article, there was a mistake in Table 2. In the last column of PLR the wrong patient number is 57. The correct patient number is 47. The corrected Table 2 appears below.

TABLE 2.

Comparison of the median OS based on the cut-off value for each significant biomarker.

CRP (mg/L) Albumin (g/L) PLR
Cut-off value >30.65 ≤30.65 ≤44.35 >44.35 >168.20 ≤168.20
n= 16 59 47 28 28 47
Median OS (months) 4.89 17.71 8.94 21.54 6.67 18.20
Mann-Whitney test (Z statistic) 3.75 3.32 3.38
p-value <0.001 <0.001 <0.001

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.


Articles from Pathology and Oncology Research are provided here courtesy of Frontiers Media SA

RESOURCES